BioSpace News Archive

Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

Innovent Biologics, Inc. announced the two-year follow-up results of TYVYT® ORIENT-4 study in relapsed or refractory Extranodal NK/T-cell lymphoma at the 56th Annual Meeting of the American Society of Clinical Oncology .

May 31, 2020
·
4 min read
Drug Development

Immutep Announces Improving Data from the Phase II TACTI-002 Study

Immutep Limited announces new interim data from its ongoing Phase II TACTI-002 study.

May 31, 2020
·
4 min read
Drug Development

Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment, Showing Improvement in Recovery Time

Pre-clinical data for Celltrion’s antiviral antibody treatment candidate demonstrate a 100-fold reduction in viral load of SARS-CoV-2 (COVID-19), as well as improvement in lung lesions

May 31, 2020
·
6 min read
Deals

Hua Medicine Selected for Inclusion in the MSCI Hong Kong Micro Cap Index

Hua Medicine, a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, is pleased to announce that the Company has been officially included as a constituent stock of the MSCI Hong Kong Micro Cap Index.

May 31, 2020
·
3 min read